Showing results (131-140 of 140) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Journal of Medicinal Chemistry|January 27, 2022
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding PoseLingtian Zhang, Marialuisa Moccia, David C Briggs, et al.The Journal of Invasive Cardiology|October 6, 2005
A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) TrialWai-Hong Chen, Upendra Kaul, Sum-Kin Leung, et al.Inorganic Chemistry|July 7, 2023
Effects of Bis(imino)acenaphthene (Bian)-Derived Ligands on the Cytotoxicity, DNA Interactions, and Redox Activity of Palladium(II) Bipyridine ComplexesVeronika I Komlyagina, Nikolai F Romashev, Victoria K Besprozvannykh, et al.Metabolomics : Official Journal of the Metabolomic Society|December 14, 2023
Maternal and newborn metabolomic changes associated with urinary polycyclic aromatic hydrocarbon metabolite concentrations at delivery: an untargeted approachJagadeesh Puvvula, Kathrine E Manz, Joseph M Braun, et al.Journal of Medical Radiation Sciences|October 5, 2020
Technical considerations for positioning and placement of a transperineal ultrasound probe during prostate radiotherapyEric Pei Ping Pang, Kellie Knight, Ronnie Wing-Kin Leung, et al.Journal of Hepatology|July 13, 2025
Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modificationYiling Chen, Derek Lee, Kenneth Kin-Leung Kwan, et al.Metabolomics : Official Journal of the Metabolomic Society|January 25, 2025
Global metabolomic alterations associated with endocrine-disrupting chemicals among pregnant individuals and newbornsJagadeesh Puvvula, Lucie C Song, Klaudia J Zalewska, et al.Blood Advances|July 23, 2026
Co-mutation of asxl1 and IDH2R172K enhances leukemogenesis and correlates with epigenetic activation of MAPK and AP-1Fangfang He, Yao Ruan, Lingge Tu, et al.Science Advances|May 5, 2023
Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer developmentJacinth Wing-Sum Cheu, David Kung-Chun Chiu, Kenneth Kin-Leung Kwan, et al.Cell Reports. Medicine|April 30, 2026
BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.Pageof 14